Medical Technology

@xconomy.com 4 years ago

MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms

@xconomy.com 5 years ago

At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments

@xconomy.com 5 years ago

Hatteras Launches New Fund With $94M for Life Science Investments

@xconomy.com 5 years ago

New Data Puts Aldeyra One Step Closer to FDA Filing for Eye Drug

@xconomy.com 5 years ago

FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take

@xconomy.com 5 years ago

JLabs’ Luby Takes the Reins at TMC Innovation Institute in Houston

@xconomy.com 5 years ago

Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More

@xconomy.com 5 years ago

Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues

@xconomy.com 5 years ago

Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines

@xconomy.com 5 years ago

With New Data, Alnylam Could Seek Speedy OK For Second RNAi Drug

@xconomy.com 5 years ago

TX Roundup: TMC’s BioBridge to the UK, New Execs at Fannin & TechFW

@xconomy.com 6 years ago

Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs